| Literature DB >> 21986356 |
G Reid1.
Abstract
In times when human life and quality of life remain threatened by infectious diseases, increasing microbial resistance and a diminished armamentarium of treatments, you might think that the European Commission would urgently seek and encourage alternative approaches. On the contrary, the European Food Safety Authority (EFSA) has created a panel that has ignored good science, over-ridden peer-reviewed medical studies, and seems intent on breaking the back of a validated approach to infectious disease management, namely probiotics. The recent rejection of a simple and quite bland claim related to vaginal health emphasises the travesty of this bureaucracy. Herein, the science fights back and counters the critique of EFSA.Entities:
Mesh:
Year: 2011 PMID: 21986356 DOI: 10.3920/BM2011.0026
Source DB: PubMed Journal: Benef Microbes ISSN: 1876-2883 Impact factor: 4.205